PharmaSGP Holding SE (ETR: PSG)

Germany flag Germany · Delayed Price · Currency is EUR
26.80
+2.00 (8.06%)
Jan 6, 2025, 11:42 AM CET
Market Cap 316.54M
Revenue (ttm) 114.00M
Net Income (ttm) 18.80M
Shares Out 11.99M
EPS (ttm) 1.57
PE Ratio 16.84
Forward PE 11.38
Dividend 1.36 (5.15%)
Ex-Dividend Date n/a
Volume 847
Open 25.00
Previous Close 24.80
Day's Range 25.00 - 26.80
52-Week Range 19.00 - 27.40
Beta -0.00
Analysts n/a
Price Target n/a
Earnings Date Mar 14, 2025

About PharmaSGP Holding SE

PharmaSGP Holding SE manufactures and sells over-the-counter drugs and other healthcare products in Germany. The company’s pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage creams for the treatment of various pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Revitensin, a drug for the treatment of hair loss; Dorisol for neuralgia (nerve ... [Read more]

Sector Healthcare
Founded 2012
Employees 89
Stock Exchange Deutsche Börse Xetra
Ticker Symbol PSG
Full Company Profile

Financial Performance

In 2023, PharmaSGP Holding SE's revenue was 101.10 million, an increase of 17.80% compared to the previous year's 85.82 million. Earnings were 16.40 million, an increase of 37.17%.

Financial Statements

News

There is no news available yet.